Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications
- PMID: 26879750
- PMCID: PMC4754238
- DOI: 10.1186/s40345-016-0047-3
Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications
Abstract
Background: Behavioral and emotional adverse events induced by drugs commonly prescribed to patients with bipolar disorders are of paramount importance to clinical practice and research. However, no reviews on the topic have been published so far.
Methods: An extensive search was performed. Reports were reviewed if they described behavioral side effects related to pharmacological treatments for bipolar disorders in healthy subjects or patients with different neuropsychiatric disorders. For this review, lithium, antipsychotics, anticonvulsants and selective serotonin reuptake inhibitors were included.
Results: Apathy or emotional blunting, diminished sexual desire, and inability to cry were reported to be associated with exposure to selective serotonin reuptake inhibitors. Neuroleptic-induced deficit syndrome/emotional detachment and obsessive-compulsive symptomatology and decision-making modifications. A lithium-related amotivational syndrome was also reported in the literature. Furthermore, hypersexuality and obsessive-compulsive symptoms have been noted in subjects treated with lamotrigine.
Limitations: Primary studies on drug-related adverse events are scant so far and most of the data currently available derive from case reports. Moreover, most of the evidence reviewed is based on studies performed on healthy subjects and patients with neuropsychiatric conditions other than bipolar disorders.
Discussion: There is a remarkable dearth of data on behavioral adverse events of pharmacological treatment for bipolar disorders. However, the pieces of evidence available at present, though scant and scattered, suggest that different behavioral adverse events may be related to pharmacological treatment for these disorders. The implications of these findings for research and management of patients with mood disorders are discussed.
Keywords: Apathy; Behavioral adverse events; Bipolar disorder; Cognition; Emotional detachment.
Similar articles
-
[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].Encephale. 2017 Oct;43(5):464-470. doi: 10.1016/j.encep.2016.09.005. Epub 2016 Nov 18. Encephale. 2017. PMID: 27871720 Review. French.
-
Treatments for late-life bipolar disorder.Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. doi: 10.1016/j.amjopharm.2006.12.007. Am J Geriatr Pharmacother. 2006. PMID: 17296540 Review.
-
[Alpha-interferon and mental disorders].Encephale. 2001 Jul-Aug;27(4):308-17. Encephale. 2001. PMID: 11686052 Review. French.
-
A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?J Affect Disord. 2008 Apr;107(1-3):307-15. doi: 10.1016/j.jad.2007.08.018. Epub 2007 Sep 21. J Affect Disord. 2008. PMID: 17889374
-
[Pharmacological treatment of bipolar disorder in children and adolescents].Encephale. 2017 May;43(3):254-258. doi: 10.1016/j.encep.2016.01.009. Epub 2016 May 16. Encephale. 2017. PMID: 27198073 Review. French.
Cited by
-
Functional Implications of the CLOCK 3111T/C Single-Nucleotide Polymorphism.Front Psychiatry. 2016 Apr 21;7:67. doi: 10.3389/fpsyt.2016.00067. eCollection 2016. Front Psychiatry. 2016. PMID: 27148095 Free PMC article.
-
Online information seeking by patients with bipolar disorder: results from an international multisite survey.Int J Bipolar Disord. 2016 Dec;4(1):17. doi: 10.1186/s40345-016-0058-0. Epub 2016 Aug 24. Int J Bipolar Disord. 2016. PMID: 27552813 Free PMC article.
-
Lithium side effects and toxicity: prevalence and management strategies.Int J Bipolar Disord. 2016 Dec;4(1):27. doi: 10.1186/s40345-016-0068-y. Epub 2016 Dec 17. Int J Bipolar Disord. 2016. PMID: 27900734 Free PMC article. Review.
-
From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy.Curr Drug Saf. 2025;20(2):120-147. doi: 10.2174/0115748863301630240417071353. Curr Drug Saf. 2025. PMID: 38676478 Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources